Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20
Sept 26 (Reuters) - Sorrento Therapeutics Inc
SRNEQ.PK :
* SORRENTO THERAPEUTICS INC- ON SEPTEMBER 20, 2023, SORRENTO
COMPLETED A REDUCTION IN U.S. HEADCOUNT FROM 215 TO 128.
Source text for Eikon: ID:
Further company coverage: SRNEQ.PK
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20